产品简要
公司名称 :
Creative Biomart
产品类型 :
抗体
产品名称 :
Anti-Human CD20 Therapeutic Antibody (Ofatumumab)
目录 :
TAB-028
规格 :
1毫克
克隆性 :
单克隆
宿主 :
人类
共轭标签 :
未共轭
反应物种 :
人类
应用 :
酶联免疫吸附测定, 免疫组化, 免疫细胞化学, 中和反应, 免疫沉淀, 流式细胞仪
更多信息或购买 :
产品信息
猫 :
TAB-028
产品名称 :
Anti-Human CD20 Therapeutic Antibody (Ofatumumab)
品牌 :
Creative Biolabs
Abbr :
Ofatumumab
宿主动物 :
人类
应用 :
, FC, IP, ELISA, Neut, FuncS, IF, IHC,
靶标 :
CD20
物种活性 :
人类
Expression Host :
CHO
Antbody Type :
工程抗体
免疫原 :
Hmuan CD20 transfected NS/O cells.
别称 :
Ofatumumab;arzerra;679818-59-8;GSK1841157;HuMax-CD20;2F2;Arzerra;HuMax-CD20;MS4A1;membrane-spanning 4-domains, subfamily A, member 1;CD20;B-lymphocyte antigen CD20;B1;Bp35;MS4A2;CD20 antigen;CD20 receptor;leukocyte surface antigen Leu-16;B-lymphocyte cell
UniProt数据库编号 :
P11836
产品简列 :
Recombinant monoclonal antibody to Human CD20. Ofatumumab (trade name Arzerra, also known as HuMax-CD20) is a human monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation. It is FDA approved for treating chronic lymphocytic leukemia that is refractory to fludarabine and alemtuzumab (Campath) and has also shown potential in treating Follicular non-Hodgkin's lymphoma, Diffuse large B cell lymphoma, rheumatoid arthritis and relapsing remitting multiple sclerosis. Ofatumumab has also received conditional approval in Europe for the treatment of refractory chronic lymphocytic leukemia. This makes ofatumumab the first marketing application for an antibody, as well as the first human monoclonal antibody which targets the CD20 molecule that will be available for patients with refractory CLL.
规格 :
1毫克
储存 :
4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided.
更多信息或购买 :
公司信息
Creative Biomart
NY, USA
contact@creative-biomart.com
http://www.creativebiomart.net
1-516-855-7709
公司总部: 美国
Creative Biomart为生物研究、临床研究、分子诊断及生物药物研发等领域,提供高质量的重组蛋白、诊断用抗原抗体、诊断用酶及制药用酶等产品。